Introduction
The major role of gap junctional intercellular communication (GJIC) is considered to be the maintenance of homeostasis in multicellular organisms. Gap junctions mediate the transfer of factors of molecular weight less than 1000 from within one cell into adjacent cells. It is believed that through GJIC the level of second messages which are important for growth control is harmonized among cells in a given tissue and that the homeostasis of a tissue can be maintained (1, 2) . Aberrant growth control vis-a-vis surrounding normal cells is an essential feature of cancer cells. Therefore, it has long been considered that altered GJIC might play an essential role in carcinogenesis (2) (3) (4) .
Recent studies on the structure of gap junction proteins have begun to reveal the fine structure and membrane topology of gap junctions. As depicted in Figure  1 , a gap junction consists of two connexons, each coming from one cell. Each connexon consists of six subunits called connexins. The connexin membrane topology is also shown in Figure 1 , and it is believed that the chain traverses the membrane four times with the C-terminal and N-terminal in cytoplasmic areas and two loops in the extracellular space (5) (6) (7) .
Although the schematic view presented in Figure 1 represents common features of connexins, there are several different proteins that are expressed in different tissues. For example, connexin 32 codes for the connexin molecule with a molecular weight of 32 kDa; it was originally isolated from the liver and is also expressed in kidney and stomach cells but not in, for example, heart cells (8) (9) (10) . On the other hand, connexin 43 , which was isolated from heart cells (11), is not expressed in hepatocytes; however, it is expressed in biliary epithelial cells and various fibroblasts. In addition to these two connexins, connexin 26 has recently been isolated as a second connexin of the liver (7). While the structure of these connexins appears to be similar, their regulation may be different. For example, connexin 26 has a shorter carboxy terminus, and therefore phosphorylation sites for cAMP-dependent protein kinase are absent in connexin 26 (7) . Antibodies and cDNA for these three different connexins have been prepared (7) (8) (9) (10) (11) (12) (13) and much used in studies of the mechanisms of function of gap junctions. While it has been reported that connexin 43 and 32 can together form functional gap junctions in Xenopus oocytes (14) , it is still not known whether such heterologous combination of connexins can occur in somatic cells.
GJIC can be modulated at various levels (15) . In addition to the usual mechanisms for modulation of protein synthesis, it is thought that GJIC can be modulated after the formation of functional gap junctions. Under certain circumstances, it is believed that the hole in a gap junction can be closed by twisting six connexin subunits (16) . Recent studies also suggest that cell-to-cell recognition may be a prerequisite for two adjacent cells to form gap junctions. The cell-cell recognition molecules include extracellular matrix and cell adhesion molecules (15 (25) (26) (27) . However, these transformed cells did not communicate with surrounding normal cells (25) (26) (27) . Similar selective lack of GJIC was observed with tumorigenic and nontumorigenic rat liver epithelial cells (28) . From these results and others, we postulated that, for cells to become cancerous, they may need to lose GJIC with their surrounding normal cells rather than losing their homologous GJIC (29) have shown the increased expression of this particular connexin (32). of cell transformation. For example, a) enhancement of cell transformation mediated by phorbol esters or diacylglycerol is related to inhibition of GJIC in these cell lines (39, 40) ; b) antitumor-promoting agents such as retinoic acid, cAMP, and glucocorticoids can antagonize phorbol-ester-mediated inhibition of intercellular communication and can inhibit cell transformation in these cell lines (41, 42) ; c) a BALB/c 3T3 cell variant that is susceptible to chemicals or UV light-mediated cell transformation lost GJIC when the cells reached culture confluence, while other cell lines did not, suggesting that the loss of GJIC in the cell transformation-susceptible cell line is related to its high transformation frequency (43) .
On the other hand, there are also several lines of evidence that suggest that block of GJIC is not necessarily related to enhanced cell transformation. For example, transforming growth factor (TGF)-P, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCCD), and okadaic acid have been shown to enhance cell transformation of BALB/c 3T3 cells or C3H1OT1/2 cells (26, 44, 45) . These agents, however, did not block GJIC in the same target cells. While it is possible that these tumor-promoting agents block GJIC only locally, including initiated cells, it is more likely that they act by different mechanisms and that these agents enhance transformation by mechanisms not involving block of GJIC. Analysis of samples during tumor progression suggests that block of GJIC is also a later event in animal carcinogenesis. For ex-ample, the analysis of cell lines established from different stages of mouse skin carcinogenesis revealed that there is a progressive decrease of GJIC as the stage of carcinogenesis advances (24) . Similarly, analysis of gap junction proteins and mRNA levels during liver carcinogenesis has revealed the progressive decrease in their expression from normal to preneoplastic foci, preneoplastic nodules, and finally to hepatocellular carcinoma (31; unpublished results).
Gap Junctional Intercellular Communication and Oncogenes
Considering the importance of signal transduction within cells, it is conceivable that a membrane event such as GJIC and nuclear factors such as cellular oncogenes influence each other and that such an interaction may play an important role in carcinogenesis. Earlier studies on the relationship between oncogenes and GJIC examined whether oncogenes can modulate GJIC. Such studies have shown that certain viral oncogenes such as the v-src gene can indeed inhibit GJIC (46) (47) (48) . Other oncogenes have also been shown to inhibit GJIC. However, some laboratories, including ours, have found no inhibitory effect of some of these oncogenes on gap junctional communication. These results are summarized in Table 2 .
In collaboration with M. Bignami and F. Tato, we examined the relationship between v-onc expression, focus formation, and GJIC in NIH 3T3 cells (49 (25) (26) (27) . However, when agents such as cAMP, retinoic acid, and glucocorticoids were added to culture dishes that contained already transformed foci, many transformed foci disappeared (42) . There was also a resumption of GJIC between transformed cells and surrounding normal cells (42 The molecular mechanisms of regulation of GJIC are not yet known. However, it is important to emphasize the possible involvement of cell adhesion molecules. We found a selective intercellular communication between transformed and nontransformed BALB/c 3T3 cells. Since both transformed and nontransformed cells communicate among themselves, but not with each other, it appears that a cell-to-cell recognition mechanism is altered. Recently, we have introduced a gene for a cell adhesion molecule into cells that were otherwise incapable of gap junction communication and found that the transfected cells did express the cell adhesion molecule and started to communicate, suggesting the direct control of GJIC by cell adhesion molecules. This also implies that it is not necessary to directly alter GJIC itself in order to block communication; instead, blocking or al-tering the cell-cell recognition mechanism may modulate GJIC. By this means, alteration of cell-cell recognition may be an important aspect involved during carcinogenesis.
As emphasized above, most available evidence for the involvement of GJIC in carcinogenesis is circumstantial. It is important now to investigate more directly the relationship between GJIC and carcinogenesis. Molecular probes such as expression vectors of gap junction proteins (connexins) and cell adhesion molecules have recently become available, which should make this possible. We expect to see rapid progress in our understanding both offundamental aspects of GJIC regulation and of its implication in multistage carcinogenesis.
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